Owkin Stock
AI Medical Research Testing
Sign up today and learn more about Owkin Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Owkin Stock
Owkin is a startup that provides machine learning that allows medical researchers to test AI models on distributed data. The company deploys AI and federated learning for medical research and aims to empower researchers in hospitals, universities, and pharmaceutical companies to understand why drug efficacy varies from patient to patient, enhance the drug development process, and identify the best drug for the right patient to improve treatment outcomes. It is backed by investors such as F-Prime Capital & Eight Roads Ventures, GV, Otium Ventures, Cathay Innovation, and NJF Capital as well as a scientific board. It was co-founded in 2016 by Thomas Clozel, a hematologist oncologist and researcher, and Gilles Wainrib, a computer science teacher-researcher in New York, New York.
Investors
Funding History
| October 2016 | $2.1M |
|---|---|
| January 2018 | $11.0M |
| May 2018 | $5.0M |
| March 2019 | $13.0M |
| May 2020 | $25.0M |
| July 2020 | $18.0M |
Management
Chief Executive Officer
Thomas Clozel
Press
pharmaphorum - Oct, 17 2023
Owkin signs up another pharma partner for its AI platformbiospace - Oct, 17 2023
Servier partners with Owkin with the aim of discovering and developing AI-driven precision therapeuticsbiospace - Oct, 12 2023
ADVANCING NOVEL CANCER THERAPIES: MOSAIC KEYNOTE PRESENTATION HEADLINES BIO-IT WORLD EUROPE, 29-30 NOVEMBER IN LONDON OWKINgenomeweb - Jun, 3 2023
Owkin, NanoString Technologies Launch $50M Spatial Omics Research Program for Cancer Researchbit - Dec, 5 2022
Owkin open sources biotech AI bundlebioworld - Sep, 3 2022
Owkin wins CE mark for two AI cancer solutionsfiercebiotech - Jun, 12 2022
Bristol Myers pays $80M to AI firm Owkin as part of cardiovascular trial accordbiospace - Jun, 11 2022
BMS Enlists Owkin's AI/ML Tech to Improve Clinical Trialsnews - Jun, 10 2022
The Week’s 10 Biggest Funding Rounds: Biotech’s Big Week; Resilience Takes Top Spot With $625M Roundbusinessinsider - Jun, 8 2022
Exclusive: Medical AI startup Owkin just secured $80 million as it gears up to launch a drug trial with the pharmaceutical giant Bristol Myers Squibbbiospace - Mar, 2 2022
Owkin welcomes leading immuno-oncology professor as Chief Medical Officer and senior pharma exec as SVP Data Sciencezpr - Dec, 25 2021
Owkin and Amgen use AI to improve cardiovascular risk predictionfiercebiotech - Dec, 24 2021
Amgen, Owkin study shows cardiac-predicting AI outperforms traditional clinical methodsdlvr - Nov, 27 2021
Sanofi invests $180 million equity in Owkin's artificial intelligence and federated learning to advance oncology pipelinedlvr - Nov, 26 2021
Digital Clinical Research Platform For Drug Development Owkin Raises $180M At A Unicorn Valuationlife-sciences-europe - Nov, 23 2021
Sanofi–Owkin: cancer drug RnD, 202111– strategic collaboration with $90m for three years + milestonessiliconcanals - Nov, 20 2021
AI-based biotech startup Owkin becomes France’s new ‘unicorn’ after raising €159M from Sanofivbank - Nov, 19 2021
AI-assisted biotech startup Owkin becomes latest French unicornfiercebiotech - Nov, 19 2021
Sanofi inks $270M cancer AI deal with R&D platform developer Owkinfinance - Nov, 19 2021
Drugmaker Sanofi invests $180 million in French AI startup Owkinbiospace - Nov, 19 2021
Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipelinebit - Nov, 13 2021
Former Sony Europe corporate comms GM Lucie Speciale rejoins Borkowskiprlog - Oct, 26 2021
Owkin awarded for its use of AI to diagnose and treat Cancerfinance - Sep, 18 2021
Owkin Enters Into Agreement to Build Innovative Methods With the Potential to Enhance AI-Enabled External Control Armsbioworld - Jul, 3 2020
AI-focused Owkin rakes in an additional $18M to series Anews - Jul, 1 2020
French-American AI Startup Owkin Closes $18M Series A To Make Medical Research More CollaborativeMedCityNews - Jul, 1 2020
Decentralized research platform Owkin raises another $18M for series ATechCrunch - May, 10 2020
Owkin raises $25 million as it builds a secure network for healthcare analysis and researchnanalyze - Jan, 22 2020
7 AI Healthcare Startups Automating Clinical Trialspharmiweb - Dec, 3 2019
Owkin teams up with NVIDIA and King's College London to deliver AI to hospitals while protecting patient data with Federated Learningfiercebiotech - Oct, 8 2019
Owkin's mesothelioma AI discovers new biomarkers from lung biopsy imagesprnewswire - Oct, 8 2019
Owkin Publishes Breakthrough Research in Nature Medicineft - Jul, 16 2019
Pharma groups combine to promote drug discovery with AImobihealthnews - May, 26 2018
Alphabet's GV invests $7 million in AI startup Owkinxconomy - May, 25 2018
A.I. for Healthcare Gets Even More Crowded as GV Invests in Owkinfinsmes - May, 25 2018
Owkin Received Additional Funding from GV; Raises $18M To-Datevator - May, 24 2018
Healthcare artificial intelligence platform OWKIN raises funding from GVvcaonline - May, 18 2018
Bruno Raillard, partner at Otium Venture, will join OWKIN’s Board of Directors, which currently includes co-founders Gilles Wainrib, Ph.D. and Thomas Clozel, M.D., and NJF Capital founder Nicole Junkermann.fiercebiotech - Jan, 25 2018
Amgen-partnered Owkin bags $11M to scale AI platformalleywatch - Jan, 21 2018
#NYCtech Week in Reviewfiercebiotech - Jan, 18 2018
Retooling drug development with next-generation machine learning, Owkin nabs $11Mtech - Jan, 18 2018
Medical data analysis startup OWKIN raises $11 millionmobihealthnews - Jan, 17 2018
Predictive analytics startup Owkin lands $11Mpehub - Jan, 17 2018
Owkin lands $11 mln Series Ahackernoon - Feb, 18 2017
Transfer learning and the rise of collaborative artificial intelligenceEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
